{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:48:32Z","timestamp":1790113712185,"version":"4.0.1"},"reference-count":202,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and IgG4-related sclerosing cholangitis (IgG4-SC) are the four main forms of autoimmune liver diseases (AILDs), which are all defined by an aberrant immune system attack on the liver. Most previous studies have shown that apoptosis and necrosis are the two major modes of hepatocyte death in AILDs. Recent studies have reported that inflammasome-mediated pyroptosis is critical for the inflammatory response and severity of liver injury in AILDs. This review summarizes our present understanding of inflammasome activation and function, as well as the connections among inflammasomes, pyroptosis, and AILDs, thus highlighting the shared features across the four disease models and gaps in our knowledge. In addition, we summarize the correlation among NLRP3 inflammasome activation in the liver-gut axis, liver injury, and intestinal barrier disruption in PBC and PSC. We summarize the differences in microbial and metabolic characteristics between PSC and IgG4-SC, and highlight the uniqueness of IgG4-SC. We explore the different roles of NLRP3 in acute and chronic cholestatic liver injury, as well as the complex and controversial crosstalk between various types of cell death in AILDs. We also discuss the most up-to-date developments in inflammasome- and pyroptosis-targeted medicines for autoimmune liver disorders.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1150879","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T05:10:58Z","timestamp":1678252258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Inflammasome and pyroptosis in autoimmune liver diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"Jixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingri","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxiong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16334","DOI":"10.20452\/pamw.16334","article-title":"Recent advances in the diagnosis and management of autoimmune hepatitis","volume":"132","author":"Dalekos","year":"2022","journal-title":"Polish Arch Internal Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the international autoimmune hepatitis group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32117","article-title":"Primary biliary cholangitis: 2021 practice guidance update from the American association for the study of liver diseases","volume":"75","author":"Lindor","year":"2022","journal-title":"Hepatol (Baltimore Md)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.11.024","article-title":"IgG : IgM ratios of liver plasma cells reveal similar phenotypes of primary biliary cholangitis with and without features of autoimmune hepatitis","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.913","article-title":"Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)","volume":"28","author":"Nakazawa","year":"2021","journal-title":"J hepato-biliary-pancreatic Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/cells10102671","article-title":"Increased intrahepatic expression of immune checkpoint molecules in autoimmune liver disease","volume":"10","author":"Macek Jilkova","year":"2021","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005635","article-title":"Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events","volume":"10","author":"Coukos","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"154705","DOI":"10.1016\/j.phymed.2023.154705","article-title":"Diallyl trisulfide inhibits monosodium urate-induced NLRP3 inflammasome activation via NOX3\/4-dependent mitochondrial oxidative stress in RAW 264.7 and bone marrow-derived macrophages","volume":"112","author":"Kim","year":"2023","journal-title":"Phytomed: Int J Phytother Phytopharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.it.2022.09.002","article-title":"Linking nutrient sensing, mitochondrial function, and PRR immune cell signaling in liver disease","volume":"43","author":"Kemper","year":"2022","journal-title":"Trends Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101320-011235","article-title":"Innate sensors trigger regulated cell death to combat intracellular infection","volume":"40","author":"Nozaki","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101220-030653","article-title":"Inflammatory caspases: Toward a unified model for caspase activation by inflammasomes","volume":"40","author":"Ross","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1082165","article-title":"Cancer-associated pyroptosis: A new license to kill tumor","volume":"14","author":"Kong","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100890","DOI":"10.1016\/j.mam.2020.100890","article-title":"Biological mechanisms and therapeutic relevance of the gasdermin family","volume":"76","author":"Xia","year":"2020","journal-title":"Mol Aspects Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13186","article-title":"Pyroptosis in neutrophils: Multimodal integration of inflammasome and regulated cell death signaling pathways","author":"Dubyak","year":"2023","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.09.003","article-title":"Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity","volume":"81","author":"Hou","year":"2021","journal-title":"Mol Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101100","DOI":"10.1016\/j.mam.2022.101100","article-title":"The human inflammasomes","volume":"88","author":"Paerewijck","year":"2022","journal-title":"Mol Aspects Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2022137","article-title":"NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease","volume":"54","author":"Guan","year":"2022","journal-title":"Acta Biochim Biophys Sin"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.09.019","article-title":"How inflammasomes inform adaptive immunity","volume":"430","author":"Evavold","year":"2018","journal-title":"J Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.896473","article-title":"Inflammasomes and pyroptosis of liver cells in liver fibrosis","volume":"13","author":"Gan","year":"2022","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3390\/ijms18112379","article-title":"Regulation and sensing of inflammasomes and their impact on intestinal health","volume":"18","author":"Ranson","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e11002","DOI":"10.15252\/emmm.201911002","article-title":"Inhibition of double-strand DNA-sensing cGAS ameliorates brain injury after ischemic stroke","volume":"12","author":"Li","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","article-title":"Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950","volume":"73","author":"Corcoran","year":"2021","journal-title":"Pharmacol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101085","DOI":"10.1016\/j.mam.2022.101085","article-title":"Caspase mechanisms in the regulation of inflammation","volume":"88","author":"Bibo-Verdugo","year":"2022","journal-title":"Mol Aspects Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1075834","article-title":"Inflammasome activation by gram-positive bacteria: Mechanisms of activation and regulation","volume":"14","author":"Keestra-Gounder","year":"2023","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"121498","DOI":"10.1016\/j.lfs.2023.121498","article-title":"Pyroptosis as a double-edged sword: The pathogenic and therapeutic roles in inflammatory diseases and cancers","volume":"318","author":"Liu","year":"2023","journal-title":"Life Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.04.004","article-title":"NLRP1 inflammasome activation in keratinocytes: Increasing evidence of important roles in inflammatory skin diseases and immunity","volume":"142","author":"Fenini","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imr.12884","article-title":"The NLRP1 and CARD8 inflammasomes","volume":"297","author":"Taabazuing","year":"2020","journal-title":"Immunol Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100863","DOI":"10.1016\/j.mam.2020.100863","article-title":"The NAIP\/NLRC4 inflammasome in infection and pathology","volume":"76","author":"Bauer","year":"2020","journal-title":"Mol Aspects Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl6324","article-title":"ZAK\u03b1-driven ribotoxic stress response activates the human NLRP1 inflammasome","volume":"377","author":"Robinson","year":"2022","journal-title":"Sci (New York NY)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2019.12.008","article-title":"Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct-ligated mouse","volume":"9","author":"Cai","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03350-4","article-title":"DPP9 sequesters the c terminus of NLRP1 to repress inflammasome activation","volume":"592","author":"Hollingsworth","year":"2021","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00015-18","article-title":"Cytosolic recognition of microbes and pathogens: Inflammasomes in action","volume":"82","author":"Hayward","year":"2018","journal-title":"Microbiol Mol Biol Rev: MMBR"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.immuni.2020.06.007","article-title":"Caspase-1 engages full-length gasdermin d through two distinct interfaces that mediate caspase recruitment and substrate cleavage","volume":"53","author":"Liu","year":"2020","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13293","article-title":"The NLRP6 inflammasome","volume":"162","author":"Zheng","year":"2021","journal-title":"Immunology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.963291","article-title":"Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.3390\/ijms22083876","article-title":"Streptococcus pneumoniaeThe critical role of NLRP6 inflammasome in infection in vitro and In vivo","volume":"22","author":"Xu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s42003-022-03491-w","article-title":"Physiological and pathophysiological functions of NLRP6: pro- and anti-inflammatory roles","volume":"5","author":"Angosto-Bazarra","year":"2022","journal-title":"Commun Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"100859","DOI":"10.1016\/j.mam.2020.100859","article-title":"NLRP6 inflammasome","volume":"76","author":"Li","year":"2020","journal-title":"Mol Aspects Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","article-title":"Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment","volume":"13","author":"Schneider","year":"2022","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"154452","DOI":"10.1016\/j.phymed.2022.154452","article-title":"Qing-Chang-Hua-Shi granule ameliorates DSS-induced colitis by activating NLRP6 signaling and regulating Th17\/Treg balance","volume":"107","author":"Cheng","year":"2022","journal-title":"Phytomed: Int J Phytother Phytopharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-0256-z","article-title":"The NLRP6 inflammasome in health and disease","volume":"13","author":"Ghimire","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4898","article-title":"A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients","volume":"12","author":"Gao","year":"2022","journal-title":"Cancer Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.09.005","article-title":"Emerging activators and regulators of inflammasomes and pyroptosis","volume":"40","author":"Xue","year":"2019","journal-title":"Trends Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0247-0","article-title":"Intestinal epithelial NAIP\/NLRC4 restricts systemic dissemination of the adapted pathogen salmonella typhimurium due to site-specific bacterial PAMP expression","volume":"13","author":"Hausmann","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202254611","article-title":"Vitamin d receptor enhances NLRC4 inflammasome activation by promoting NAIPs-NLRC4 association","volume":"23","author":"Chen","year":"2022","journal-title":"EMBO Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.02.099","article-title":"NLRC4 inflammasome activation regulated by TNF-\u03b1 promotes inflammatory responses in nonalcoholic fatty liver disease","volume":"511","author":"Chen","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1002\/ijc.31827","article-title":"AIM2 deficiency reduces the development of hepatocellular carcinoma in mice","volume":"143","author":"Mart\u00ednez-Cardona","year":"2018","journal-title":"Int J Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28893","article-title":"Redox-dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice","volume":"65","author":"Sun","year":"2017","journal-title":"Hepatol (Baltimore Md)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.3390\/ijms23137447","article-title":"The P2X7R-NLRP3 and AIM2 inflammasome platforms mark the Complexity\/Severity of viral or metabolic liver damage","volume":"23","author":"Rossi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.07.010","article-title":"Advances in inflammasome research: Recent breakthroughs and future hurdles","volume":"26","author":"Tweedell","year":"2020","journal-title":"Trends Mol Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005103","article-title":"Bile acid analogues are activators of pyrin inflammasome","volume":"294","author":"Alimov","year":"2019","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.3390\/ijms21249682","article-title":"Cell death in liver diseases: A review","volume":"21","author":"Shojaie","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133","article-title":"Plasma membrane changes during programmed cell deaths","volume":"28","author":"Zhang","year":"2018","journal-title":"Cell Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04717-x","article-title":"Group a streptococcus induces GSDMA-dependent pyroptosis in keratinocytes","volume":"605","author":"LaRock","year":"2022","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-022-01011-0","article-title":"Suicide signaling by GSDMA: a single-molecule mechanism for recognition and defense against SpeB-expressing GAS","volume":"7","author":"Symmank","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-021-04384-4","article-title":"Streptococcal pyrogenic exotoxin b cleaves GSDMA and triggers pyroptosis","volume":"602","author":"Deng","year":"2022","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1038\/s41586-022-05109-x","article-title":"Author correction: Streptococcal pyrogenic exotoxin b cleaves GSDMA and triggers pyroptosis","volume":"608","author":"Deng","year":"2022","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme a from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Sci (New York NY)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S246948","article-title":"Role of GSDMB in pyroptosis and cancer","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manage Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-020-0575-z","article-title":"PD-L1-mediated gasdermin c expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis","volume":"22","author":"Hou","year":"2020","journal-title":"Nat Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12859-022-04726-7","article-title":"Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma","volume":"23","author":"Xing","year":"2022","journal-title":"BMC Bioinf"},{"key":"B65","doi-asserted-by":"publisher","first-page":"9141117","DOI":"10.1155\/2022\/9141117","article-title":"Development of a prognostic model based on pyroptosis-related genes in pancreatic adenocarcinoma","volume":"2022","author":"Su","year":"2022","journal-title":"Dis Markers"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166422","article-title":"Gasdermin c is upregulated by inactivation of transforming growth factor \u03b2 receptor type II in the presence of mutated apc, promoting colorectal cancer proliferation","volume":"11","author":"Miguchi","year":"2016","journal-title":"PloS One"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.02.006","article-title":"Gasdermin d in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668602","article-title":"Saccharomyces cerevisiaeHeterologous expression and auto-activation of human pro-inflammatory caspase-1 in and comparison to caspase-8","volume":"12","author":"Valenti","year":"2021","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154277","article-title":"GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis","author":"Chauhan","year":"2022","journal-title":"EMBO Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2018.07.002","article-title":"Mechanisms of gasdermin family members in inflammasome signaling and cell death","volume":"430","author":"Feng","year":"2018","journal-title":"J Mol Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.926796","article-title":"A systematic pan-cancer analysis of the gasdermin (GSDM) family of genes and their correlation with prognosis, the tumor microenvironment, and drug sensitivity","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Genet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/genes13010149","article-title":"PJVKNovel pathogenic variants in, the gene encoding pejvakin, in subjects with autosomal recessive non-syndromic hearing impairment and auditory neuropathy spectrum disorder","volume":"13","author":"Dom\u00ednguez-Ruiz","year":"2022","journal-title":"Genes"},{"key":"B73","doi-asserted-by":"publisher","first-page":"108270","DOI":"10.1016\/j.intimp.2021.108270","article-title":"Pan-cancer analysis reveals the expression, genetic alteration and prognosis of pyroptosis key gene GSDMD","volume":"101","author":"Qiu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"10124","DOI":"10.3390\/ijms231710124","article-title":"Anti-inflammation and anti-pyroptosis activities of mangiferin via suppressing NF-\u03baB\/NLRP3\/GSDMD signaling cascades","volume":"23","author":"Feng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.immuni.2020.06.019","article-title":"Snapshot of a deadly embrace: The caspase-1-GSDMD interface","volume":"53","author":"Vande Walle","year":"2020","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","first-page":"100924","DOI":"10.1016\/j.mam.2020.100924","article-title":"An overview of the non-canonical inflammasome","volume":"76","author":"Downs","year":"2020","journal-title":"Mol Aspects Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41401-021-00739-9","article-title":"ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome","volume":"43","author":"Wu","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-018-9640-5","article-title":"Microparticulate P2X7 and GSDM-d mediated regulation of functional IL-1\u03b2 release","volume":"15","author":"Mitra","year":"2019","journal-title":"Purinergic Signalling"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.921765","article-title":"Epigenetic aspects and prospects in autoimmune hepatitis","volume":"13","author":"Czaja","year":"2022","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"104467","DOI":"10.1016\/j.cellimm.2021.104467","article-title":"C6orf120 gene knockout in rats mitigates concanavalin a\u2212induced autoimmune hepatitis via regulating NKT cells","volume":"371","author":"Wu","year":"2022","journal-title":"Cell Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"8197937","DOI":"10.1155\/2018\/8197937","article-title":"The role of invariant NKT in autoimmune liver disease: Can vitamin d act as an immunomodulator","volume":"2018","author":"Smyk","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.08.010","article-title":"Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity","volume":"10","author":"Fu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B83","doi-asserted-by":"publisher","first-page":"13578","DOI":"10.3390\/ijms222413578","article-title":"Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms","volume":"22","author":"Sirbe","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.898615","article-title":"Animal models for autoimmune hepatitis: Are current models good enough","volume":"13","author":"Christen","year":"2022","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01717-22","article-title":"Multi-omics analysis reveals the protection of gasdermin d in concanavalin a-induced autoimmune hepatitis","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2016.699","article-title":"Nod-like receptor protein 3 inflammasome activation by escherichia coli RNA induces transforming growth factor beta 1 secretion in hepatic stellate cells","volume":"16","author":"Wang","year":"2016","journal-title":"Bosnian J Basic Med Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"114067","DOI":"10.1016\/j.ecoenv.2022.114067","article-title":"Effects of mitochondrial reactive oxygen species-induced NLRP3 inflammasome activation on trichloroethylene-mediated kidney immune injury","volume":"244","author":"Xie","year":"2022","journal-title":"Ecotoxicol Environ Safety"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.09.014","article-title":"Ragulator-rag and ROS TORment gasdermin d pore formation","volume":"42","author":"Magupalli","year":"2021","journal-title":"Trends Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00758","article-title":"NOD-like receptor protein 3 inflammasome-dependent IL-1\u03b2 accelerated ConA-induced hepatitis","volume":"9","author":"Luan","year":"2018","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2019.2283","article-title":"Attenuation of experimental autoimmune hepatitis in mice with bone mesenchymal stem cell-derived exosomes carrying MicroRNA-223-3p","volume":"42","author":"Lu","year":"2019","journal-title":"Mol Cells"},{"key":"B92","doi-asserted-by":"publisher","first-page":"110558","DOI":"10.1016\/j.biopha.2020.110558","article-title":"MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets","volume":"130","author":"Huang","year":"2020","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-022-05499-3","article-title":"MicroRNA-223 downregulation promotes HBx-induced podocyte pyroptosis by targeting the NLRP3 inflammasome","volume":"167","author":"Yu","year":"2022","journal-title":"Arch Virol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6852661","DOI":"10.1155\/2022\/6852661","article-title":"MSC-derived extracellular vesicles activate mitophagy to alleviate renal Ischemia\/Reperfusion injury via the miR-223-3p\/NLRP3 axis","volume":"2022","author":"Sun","year":"2022","journal-title":"Stem Cells Int"},{"key":"B95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","article-title":"BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis","volume":"93","author":"Chen","year":"2018","journal-title":"Mol Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825428","article-title":"Direct inhibition of GSDMD by PEITC reduces hepatocyte pyroptosis and alleviates acute liver injury in mice","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/ph15091130","article-title":"Magnesium isoglycyrrhizinate attenuates anti-tuberculosis drug-induced liver injury by enhancing intestinal barrier function and inhibiting the LPS\/TLRs\/NF-\u03baB signaling pathway in mice","volume":"15","author":"Gong","year":"2022","journal-title":"Pharm (Basel Switzerland)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"113688","DOI":"10.1016\/j.biopha.2022.113688","article-title":"Chemical inhibition of TRAF6-TAK1 axis as therapeutic strategy of endotoxin-induced liver disease","volume":"155","author":"Kim","year":"2022","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.893912","article-title":"The regulation and modification of GSDMD signaling in diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16023","article-title":"Review article: pathophysiology and management of primary biliary cholangitis","volume":"52","author":"Leung","year":"2020","journal-title":"Alimentary Pharmacol Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27313","article-title":"Ongoing activation of autoantigen-specific b cells in primary biliary cirrhosis","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatol (Baltimore Md)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatol (Baltimore Md)"},{"key":"B105","doi-asserted-by":"publisher","first-page":"102328","DOI":"10.1016\/j.jaut.2019.102328","article-title":"The challenges of primary biliary cholangitis: What is new and what needs to be done","volume":"105","author":"Terziroli Beretta-Piccoli","year":"2019","journal-title":"J Autoimmunity"},{"key":"B106","doi-asserted-by":"publisher","first-page":"118864","DOI":"10.1016\/j.carbpol.2021.118864","article-title":"Pectic polysaccharide from smilax china l. ameliorated ulcerative colitis by inhibiting the galectin-3\/NLRP3 inflammasome pathway","volume":"277","author":"Pan","year":"2022","journal-title":"Carbohydr Polymers"},{"key":"B107","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3390\/ijms21145097","article-title":"Galectin-3 in inflammasome activation and primary biliary cholangitis development","volume":"21","author":"Arsenijevic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.10.014","article-title":"Gal3 links inflammation and insulin resistance","volume":"24","author":"Siwicki","year":"2016","journal-title":"Cell Metab"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms23031170","article-title":"Gal3 plays a deleterious role in a mouse model of endotoxemia","volume":"23","author":"Fern\u00e1ndez-Mart\u00edn","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.10.038","article-title":"Sepsis-induced liver dysfunction was ameliorated by propofol via suppressing hepatic lipid peroxidation, inflammation, and drug interactions","volume":"213","author":"Wu","year":"2018","journal-title":"Life Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600392RR","article-title":"Galectin-3 regulates inflammasome activation in cholestatic liver injury","volume":"30","author":"Tian","year":"2016","journal-title":"FASEB J"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13148","article-title":"Tim-3 suppresses autoimmune hepatitis via the p38\/MKP-1 pathway in Th17 cells","volume":"11","author":"Wu","year":"2021","journal-title":"FEBS Open Bio"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced T-helper 17 differentiation in patients with primary sclerosing cholangitis (PSC)","volume":"72","author":"Kunzmann","year":"2020","journal-title":"Hepatol (Baltimore Md)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"101599","DOI":"10.1016\/j.molmet.2022.101599","article-title":"Targeting hepatic oxidative stress rescues bone loss in liver fibrosis","volume":"66","author":"Sonoda","year":"2022","journal-title":"Mol Metab"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.02.019","article-title":"Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic \u03b3\u03b4 T-cell receptor-positive cells and pathogenesis of cholestatic liver disease","volume":"154","author":"Tedesco","year":"2018","journal-title":"Gastroenterology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13060","article-title":"Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17(+) neutrophils","volume":"36","author":"Macek Jilkova","year":"2016","journal-title":"Liver Int"},{"key":"B117","doi-asserted-by":"publisher","first-page":"108892","DOI":"10.1016\/j.intimp.2022.108892","article-title":"Thiamine pretreatment improves endotoxemia-related liver injury and cholestatic complications by regulating galactose metabolism and inhibiting macrophage activation","volume":"108","author":"Li","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"23348","DOI":"10.1038\/srep23348","article-title":"Deletion of galectin-3 enhances xenobiotic induced murine primary biliary cholangitis by facilitating apoptosis of BECs and release of autoantigens","volume":"6","author":"Arsenijevic","year":"2016","journal-title":"Sci Rep"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01309","article-title":"Novosphyngobium aromaticivoransGal-3 deficiency suppresses inflammasome activation and IL-17 driven autoimmune cholangitis in mice","volume":"10","author":"Arsenijevic","year":"2019","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026246118","article-title":"Galectin-3 promotes noncanonical inflammasome activation through intracellular binding to lipopolysaccharide glycans","volume":"118","author":"Lo","year":"2021","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318487","article-title":"Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches","volume":"68","author":"Mooser","year":"2019","journal-title":"Gut"},{"key":"B122","doi-asserted-by":"publisher","first-page":"S1542-3565(22)00879-5","DOI":"10.1016\/j.cgh.2022.09.006","article-title":"Bile duct colonization with enterococcus sp. associates with disease progression in primary sclerosing cholangitis","author":"Zigmond","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.46405","article-title":"The gut-liver axis in immune remodeling: New insight into liver diseases","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/nu13031018","article-title":"The gut-liver axis in cholestatic liver diseases","volume":"13","author":"Blesl","year":"2021","journal-title":"Nutrients"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15512","article-title":"Gut-liver-axis: Barrier function of liver sinusoidal endothelial cell","volume":"36","author":"Wang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785287","article-title":"Complement inhibition alleviates cholestatic liver injury through mediating macrophage infiltration and function in mice","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.980768","article-title":"Gut microbiome and hepatic autoimmunity","volume":"13","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Front Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15142","article-title":"Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota","volume":"112","author":"Ohtani","year":"2021","journal-title":"Cancer Sci"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.702890","article-title":"Gut-liver axis: Liver sinusoidal endothelial cells function as the hepatic barrier in colitis-induced liver injury","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00281-022-00936-6","article-title":"The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts","volume":"44","author":"Liwinski","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cmet.2020.11.018","article-title":"Apaf-1 pyroptosome senses mitochondrial permeability transition","volume":"33","author":"Xu","year":"2021","journal-title":"Cell Metab"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M062653","article-title":"Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties","volume":"56","author":"Sousa","year":"2015","journal-title":"J Lipid Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"109712","DOI":"10.1016\/j.biopha.2019.109712","article-title":"Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and cyt-C\/Apaf-1\/Caspase-9\/Caspase-3 signaling pathway in vitro","volume":"122","author":"Li","year":"2020","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e0219782","DOI":"10.1371\/journal.pone.0219782","article-title":"Cullin-4B E3 ubiquitin ligase mediates apaf-1 ubiquitination to regulate caspase-9 activity","volume":"14","author":"Ohta","year":"2019","journal-title":"PloS One"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28116","article-title":"High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires","volume":"63","author":"Liaskou","year":"2016","journal-title":"Hepatol (Baltimore Md)"},{"key":"B137","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","article-title":"Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis","volume":"147","author":"Liaskou","year":"2014","journal-title":"Gastroenterology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30061","article-title":"Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis","volume":"68","author":"Taylor","year":"2018","journal-title":"Hepatol (Baltimore Md)"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx050","article-title":"Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease","volume":"11","author":"Gwela","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.05.023","article-title":"Interferon-\u03b3-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"71","author":"Ravichandran","year":"2019","journal-title":"J Hepatol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: A systematic review of population-based studies","volume":"20","author":"Trivedi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jceh.2021.10.001","article-title":"Recognizing dysfunctional innate and adaptive immune responses contributing to liver damage in patients with cirrhosis","volume":"12","author":"Goel","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15339","article-title":"Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.5009\/gnl20032","article-title":"Leaky gut and gut-liver axis in liver cirrhosis: Clinical studies update","volume":"15","author":"Fukui","year":"2021","journal-title":"Gut Liver"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i29.5412","article-title":"Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis","volume":"23","author":"Tornai","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1053\/j.gastro.2020.12.058","article-title":"Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis","volume":"160","author":"Kummen","year":"2021","journal-title":"Gastroenterology"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000604","article-title":"Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: A conceptional framework","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12072-020-10089-z","article-title":"Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis","volume":"15","author":"Lapidot","year":"2021","journal-title":"Hepatol Int"},{"key":"B149","doi-asserted-by":"publisher","first-page":"gutjnl-2021-326500","DOI":"10.1136\/gutjnl-2021-326500","article-title":"Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC","author":"Awoniyi","year":"2022","journal-title":"Gut"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.923599","article-title":"The role of gut microbiota in some liver diseases: From an immunological perspective","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am J Pathol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.07.007","article-title":"Knockout of the tachykinin receptor 1 in the Mdr2 (Abcb4) mouse model of primary sclerosing cholangitis reduces biliary damage and liver fibrosis","volume":"190","author":"Ceci","year":"2020","journal-title":"Am J Pathol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"115205","DOI":"10.1016\/j.jep.2022.115205","article-title":"The Chinese medicine babaodan suppresses LPS-induced sepsis by inhibiting NLRP3-mediated inflammasome activation","volume":"292","author":"Li","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12866-021-02171-9","article-title":"Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -\/- mouse model","volume":"21","author":"Behary","year":"2021","journal-title":"BMC Microbiol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.10.010","article-title":"Nlrp3 activation induces il-18 synthesis and affects the epithelial barrier function in reactive cholangiocytes","volume":"187","author":"Maroni","year":"2017","journal-title":"Am J Pathol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1194\/jlr.M088070","article-title":"[object Object]Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in mice","volume":"60","author":"Wang","year":"2019","journal-title":"J Lipid Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"BSR20200689","DOI":"10.1042\/BSR20200689","article-title":"NLRP3 receptor contributes to protection against experimental antigen-mediated cholangitis","volume":"40","author":"Gonz\u00e1lez","year":"2020","journal-title":"Biosci Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31494","article-title":"Bidirectional role of NLRP3 during acute and chronic cholestatic liver injury","volume":"73","author":"Frissen","year":"2021","journal-title":"Hepatol (Baltimore Md)"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00200","article-title":"Calcipotriol inhibits NLRP3 signal through YAP1 activation to alleviate cholestatic liver injury and fibrosis","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-immunol-112019-072301","article-title":"The antisocial network: Cross talk between cell death programs in host defense","volume":"39","author":"Snyder","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12988","article-title":"Biliary and hepatic involvement in IgG4-related disease","volume":"40","author":"Joshi","year":"2014","journal-title":"Alimentary Pharmacol Ther"},{"key":"B162","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/jpm12060855","article-title":"Clinical utility of personalized serum IgG subclass ratios for the differentiation of IgG4-related sclerosing cholangitis (IgG4-SC) from primary sclerosing cholangitis (PSC) and cholangiocarcinoma (CCA)","volume":"12","author":"Park","year":"2022","journal-title":"J Personalized Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5009\/gnl210116","article-title":"Classification and diagnostic criteria for IgG4-related sclerosing cholangitis","volume":"16","author":"Naitoh","year":"2022","journal-title":"Gut Liver"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.06.009","article-title":"Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis","volume":"21","author":"Lanzillotta","year":"2021","journal-title":"Pancreatology"},{"key":"B165","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/gutjnl-2020-323565","article-title":"Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"B166","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jhbp.793","article-title":"Epidemiological features of immunoglobulin G4-related sclerosing cholangitis in Japan","volume":"27","author":"Tanaka","year":"2020","journal-title":"J hepato-biliary-pancreatic Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15192","article-title":"A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis","volume":"42","author":"Radford-Smith","year":"2022","journal-title":"Liver Int"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i23.3126","article-title":"Review of primary sclerosing cholangitis with increased IgG4 levels","volume":"26","author":"Manganis","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.132","article-title":"IgG4-related hepatobiliary disease: an overview","volume":"13","author":"Culver","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30095","article-title":"The immunobiology of receptor activator for nuclear factor kappa b ligand and myeloid-derived suppressor cell activation in immunoglobulin G4-related sclerosing cholangitis","volume":"68","author":"Lian","year":"2018","journal-title":"Hepatol (Baltimore Md)"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000020","article-title":"Activated T-follicular helper 2 cells are associated with disease activity in IgG4-related sclerosing cholangitis and pancreatitis","volume":"10","author":"Cargill","year":"2019","journal-title":"Clin Trans Gastroenterol"},{"key":"B172","article-title":"Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion","volume":"25","author":"Zeng","year":"2019","journal-title":"Mol Vision"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients","volume":"77","author":"Singh","year":"2016","journal-title":"Cytokine"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12908","article-title":"Therapeutic modulation of inflammasome pathways","volume":"297","author":"Chauhan","year":"2020","journal-title":"Immunol Rev"},{"key":"B177","doi-asserted-by":"publisher","first-page":"108867","DOI":"10.1016\/j.intimp.2022.108867","article-title":"Dimethyl fumarate ameliorates autoimmune hepatitis in mice by blocking NLRP3 inflammasome activation","volume":"108","author":"Shi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14483","article-title":"Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease","volume":"40","author":"Sangineto","year":"2020","journal-title":"Liver Int"},{"key":"B179","doi-asserted-by":"publisher","first-page":"115223","DOI":"10.1016\/j.jep.2022.115223","article-title":"Cucurbitacin e glucoside alleviates concanavalin a-induced hepatitis through enhancing SIRT1\/Nrf2\/HO-1 and inhibiting NF-\u0138B\/NLRP3 signaling pathways","volume":"292","author":"Mohamed","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.3390\/molecules27185797","article-title":"Assessment of AI-based protein structure prediction for the NLRP3 target","volume":"27","author":"Yin","year":"2022","journal-title":"Mol (Basel Switzerland)"},{"key":"B181","doi-asserted-by":"publisher","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3390\/cells10112959","article-title":"The gut-liver axis in chronic liver disease: A macrophage perspective","volume":"10","author":"De Muynck","year":"2021","journal-title":"Cells"},{"key":"B183","doi-asserted-by":"publisher","first-page":"154427","DOI":"10.1016\/j.phymed.2022.154427","article-title":"Prim-o-glucosycimifugin attenuates liver injury in septic mice by inhibiting NLRP3 inflammasome\/caspase-1 signaling cascades in macrophages","volume":"106","author":"Liu","year":"2022","journal-title":"Phytomed: Int J Phytother Phytopharmacol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0041","article-title":"Treg-dominant tumor microenvironment is responsible for hyperprogressive disease after PD-1 blockade therapy","volume":"10","author":"Wakiyama","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B185","doi-asserted-by":"publisher","first-page":"8479868","DOI":"10.1155\/2021\/8479868","article-title":"Paeoniflorin protects against ANIT-induced cholestatic liver injury in rats via the activation of SIRT1-FXR signaling pathway","volume":"2021","author":"Chen","year":"2021","journal-title":"Evidence-Based Complement Altern Med: eCAM"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1590\/ACB361106","article-title":"Paeoniflorin mitigates PBC-induced liver fibrosis by repressing NLRP3 formation","volume":"36","author":"Zhang","year":"2022","journal-title":"Acta Cirurgica Brasileira"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7471","article-title":"Paeoniflorin ameliorates lipopolysaccharide-induced acute liver injury by inhibiting oxidative stress and inflammation via SIRT1\/FOXO1a\/SOD2 signaling in rats","volume":"36","author":"Li","year":"2022","journal-title":"Phytother Res: PTR"},{"key":"B188","doi-asserted-by":"publisher","first-page":"e12932","DOI":"10.1111\/eci.12932","article-title":"Indirubin and NAD prevent mitochondrial ischaemia\/reperfusion damage in fatty livers","volume":"48","author":"Teodoro","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"B189","doi-asserted-by":"publisher","first-page":"115222","DOI":"10.1016\/j.bcp.2022.115222","article-title":"Schisandrol b protects against cholestatic liver injury by inhibiting pyroptosis through pregnane X receptor","volume":"204","author":"Liang","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/toxsci\/kfx114","article-title":"Sex-differential responses of tumor promotion-associated genes and dysregulation of novel long noncoding RNAs in constitutive androstane receptor-activated mouse liver","volume":"159","author":"Lodato","year":"2017","journal-title":"Toxicol Sci"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-020-01364-0","article-title":"Oridonin attenuates TNBS-induced post-inflammatory irritable bowel syndrome via PXR\/NF-\u03baB signaling","volume":"44","author":"Shao","year":"2021","journal-title":"Inflammation"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316670","article-title":"Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis","volume":"68","author":"Liao","year":"2019","journal-title":"Gut"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X22500562","article-title":"Nrf2-dependent protective effect of paeoniflorin on \u03b1-naphthalene isothiocyanate-induced hepatic injury","volume":"50","author":"Mao","year":"2022","journal-title":"Am J Chin Med"},{"key":"B194","doi-asserted-by":"publisher","first-page":"102404","DOI":"10.1016\/j.redox.2022.102404","article-title":"Inhibition of NLRP3-mediated crosstalk between hepatocytes and liver macrophages by geniposidic acid alleviates cholestatic liver inflammatory injury","volume":"55","author":"Song","year":"2022","journal-title":"Redox Biol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.760722","article-title":"NLRP6-dependent pyroptosis-related lncRNAs predict the prognosis of hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med"},{"key":"B196","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/cells11020182","article-title":"NLRP6 inflammasome modulates disease progression in a chronic-Plus-Binge mouse model of alcoholic liver disease","volume":"11","author":"Mainz","year":"2022","journal-title":"Cells"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.781427","article-title":"The pyroptosis-related gene signature predicts the prognosis of hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.12.033","article-title":"Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score","volume":"74","author":"De Martin","year":"2021","journal-title":"J Hepatol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319057","article-title":"Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis","volume":"69","author":"Harms","year":"2020","journal-title":"Gut"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17226","article-title":"Liver-transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid","volume":"56","author":"de Veer","year":"2022","journal-title":"Alimentary Pharmacol Ther"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17277","article-title":"Multi-faceted role of pyroptosis mediated by inflammasome in liver fibrosis","volume":"26","author":"Yang","year":"2022","journal-title":"J Cell Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1150879\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T05:11:02Z","timestamp":1678252262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1150879\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":202,"alternative-id":["10.3389\/fimmu.2023.1150879"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1150879","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"1150879"}}